Weis Markets
WMK
73.26
+0.66
+0.91%
Weis Markets
US · WMK
#2859 by market cap
Listed 1970
73.26
+0.66
+0.91%
Live - 5344 symbols - heartbeat 478s ago
· 2026-10-08 07:24
Pre-market
72.71
-0.75%
After-hours
73.70
+0.60%
- Market cap
- 1.81B
- P/E (TTM)i
- 18.27
- P/Bi
- 1.31
- EPSi
- 3.65
- Div yieldi
- 1.86%
- 52W posi
- 58%
Reader sentiment
Are you bullish or bearish on WMK?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Good
- Altman Z-Score is 5.56, above the 3.0 "safe zone" threshold.
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 8 years
Latest year +3.46% YoY
Margins
- Gross margin
- 25.01%
- Operating margin
- 2.29%
- Net margin
- 1.89%
Key ratios & quality
- Altman Z-Scorei
- 5.56
Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 3.51B | 3.54B | 4.11B | 4.22B | 4.71B | 4.71B | 4.79B | 4.96B |
| Gross profit | 935.00M | 938.19M | 1.10B | 1.12B | 1.20B | 1.18B | 1.20B | 1.24B |
| Selling & admin expenses | -- | -- | -- | -- | -- | -- | -- | -- |
| Research & development | -- | -- | -- | -- | -- | -- | -- | -- |
| Operating profit | 82.67M | 84.64M | 163.18M | 146.71M | 157.05M | 133.14M | 126.39M | 113.65M |
| Pretax profit | 82.14M | 88.64M | 163.68M | 148.31M | 160.78M | 142.65M | 144.95M | 123.95M |
| Tax | 19.40M | 20.66M | 44.76M | 39.46M | 35.58M | 41.80M | 38.92M | 30.26M |
| Net profit | 62.74M | 67.98M | 118.92M | 108.85M | 125.20M | 100.85M | 106.02M | 93.69M |
| Basic EPS | 2 | 3 | 4 | 4 | 5 | 4 | 4 | 4 |
| Diluted EPS | 2.33 | 2.53 | 4.42 | 4.05 | 4.65 | 3.75 | 3.94 | 3.65 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Revenue | 1.20B | 1.22B | 1.24B | 1.30B | 1.26B | 1.28B |
| Gross profit | 298.24M | 306.67M | 308.69M | 323.31M | 330.25M | 328.40M |
| Selling & admin expenses | -- | -- | -- | -- | -- | -- |
| Research & development | -- | -- | -- | -- | -- | -- |
| Operating profit | 21.77M | 30.24M | 22.38M | 36.31M | 35.70M | 29.11M |
| Pretax profit | 26.54M | 33.37M | 24.09M | 36.99M | 37.38M | 30.66M |
| Tax | 6.99M | 8.09M | 5.85M | 8.54M | 9.52M | 7.80M |
| Net profit | 19.55M | 25.28M | 18.23M | 28.45M | 27.85M | 22.86M |
| Basic EPS | 1 | 1 | 1 | 1 | 1 | 1 |
| Diluted EPS | 0.73 | 0.96 | 0.74 | 1.24 | 1.13 | 0.92 |
Balance sheet
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 469.12M | 508.29M | 626.20M | 671.66M | 741.17M | 832.21M | 828.00M | 681.24M |
| Cash & ST investments | 106.79M | 149.34M | 271.23M | 318.85M | 367.11M | 436.86M | 413.42M | 247.57M |
| Inventory | 280.76M | 279.81M | 269.02M | 269.59M | 293.27M | 296.16M | 292.04M | 287.53M |
| Total assets | 1.43B | 1.68B | 1.82B | 1.91B | 1.96B | 2.04B | 2.09B | 2.03B |
| Total current liabilities | 267.21M | 291.94M | 346.27M | 345.20M | 345.35M | 340.78M | 343.30M | 352.73M |
| Short-term debt | -- | 39.11M | 39.17M | 39.94M | 43.53M | 40.66M | 39.34M | 39.64M |
| Long-term debt | -- | -- | -- | -- | -- | -- | -- | -- |
| Total liabilities | 409,112,000.00 | 616,817,000.00 | 674,306,000.00 | 690,733,000.00 | 657,316,000.00 | 665,295,000.00 | 656,947,000.00 | 675,449,000.00 |
| Total equity | 1.02B | 1.06B | 1.15B | 1.22B | 1.30B | 1.37B | 1.43B | 1.35B |
| Retained earnings | 1.16B | 1.20B | 1.28B | 1.36B | 1.45B | 1.52B | 1.58B | 1.64B |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Total current assets | 806.47M | 659.03M | 679.71M | 681.24M | 674.58M | 677.79M |
| Cash & ST investments | 367.64M | 219.54M | 209.82M | 247.57M | 230.90M | 243.64M |
| Inventory | 314.31M | 316.61M | 323.38M | 287.53M | 298.68M | 296.90M |
| Total assets | 2.08B | 1.96B | 2.02B | 2.03B | 2.03B | 2.04B |
| Total current liabilities | 325.85M | 328.32M | 350.71M | 352.73M | 330.56M | 333.53M |
| Short-term debt | 40.02M | 39.13M | 39.62M | 39.64M | 39.67M | 39.95M |
| Long-term debt | -- | -- | -- | -- | -- | -- |
| Total liabilities | 624,376,000.00 | 628,710,000.00 | 674,385,000.00 | 675,449,000.00 | 656,284,000.00 | 658,184,000.00 |
| Total equity | 1.46B | 1.33B | 1.34B | 1.35B | 1.37B | 1.39B |
| Retained earnings | 1.60B | 1.62B | 1.63B | 1.64B | 1.66B | 1.67B |
Cash flow
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 150.26M | 171.69M | 277.99M | 227.71M | 218.02M | 201.60M | 187.47M | 207.21M |
| Depreciation & amortization | 93.57M | 93.71M | 99.37M | 102.80M | 104.03M | 108.44M | 113.88M | 124.79M |
| Free cash flow | 51.03M | 68.74M | 146.87M | 75.70M | 95.04M | 96.52M | 21.87M | 3.30M |
| Dividends paid | -32.55M | -33.35M | -33.35M | -33.62M | -34.97M | -36.58M | -36.58M | -35.12M |
| Stock buybacks / issuance | -- | -- | -- | -- | -- | 0 | 0 | -140.00M |
| Ending cash balance | 37.81M | 66.87M | 136.61M | 86.05M | 158.00M | 184.22M | 190.32M | 117.09M |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Operating cash flow | 4.86M | 56.56M | 59.20M | 86.59M | 30.25M | 65.05M |
| Depreciation & amortization | 29.62M | 30.60M | 31.74M | 32.83M | 31.46M | 32.05M |
| Free cash flow | -28.32M | 64.00K | -4.71M | 36.27M | -9.08M | 16.27M |
| Dividends paid | -9.15M | -9.15M | -8.41M | -8.41M | -8.41M | -8.41M |
| Stock buybacks / issuance | -- | -- | 0 | 0 | -- | -- |
| Ending cash balance | 167.93M | 61.91M | 54.65M | 117.09M | 97.72M | 103.53M |
Returns & efficiency
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | 6.22 | 6.53 | 10.79 | 9.20 | 9.93 | 7.76 | 7.80 | 6.70 |
| ROA %i | 4.37 | 4.38 | 6.80 | 5.84 | 6.47 | 5.19 | 5.30 | 4.53 |
| ROIC %i | 6.22 | 5.40 | 9.04 | 7.84 | 8.61 | 6.82 | 6.92 | 5.96 |
| 5-year avg ROE %i | 7.91 | 7.92 | 8.70 | 8.60 | 8.54 | 8.80 | 9.00 | 8.19 |
| EBIT margin %i | 2.38 | 2.39 | 3.97 | 3.47 | 3.34 | 2.92 | 2.75 | 2.29 |
| FCF / sales %i | 1.40 | 1.94 | 3.57 | 1.79 | 2.02 | 2.05 | 0.46 | 0.07 |
| Current ratioi | 1.76 | 1.74 | 1.81 | 1.95 | 2.15 | 2.44 | 2.41 | 1.93 |
| Quick ratioi | 0.61 | 0.70 | 0.95 | 1.07 | 1.21 | 1.47 | 1.44 | 0.99 |
| Debt / assetsi | 0.00 | 13.06 | 11.44 | 10.55 | 9.49 | 8.97 | 8.30 | 8.49 |
| LT debt / equityi | -- | 16.97 | 14.75 | 13.25 | 10.94 | 10.36 | 9.36 | 9.80 |
| Interest coveragei | -- | -- | -- | -- | -- | -- | -- | -- |
| Revenue CAGR (3Y) %i | 6.85 | 4.15 | 5.86 | 6.38 | 9.98 | 4.66 | 4.29 | 1.69 |
| Net income CAGR (3Y) %i | 1.88 | -7.95 | 6.51 | 20.16 | 22.57 | -5.34 | -0.87 | -9.21 |
| FCF CAGR (3Y) %i | 5.16 | 150.67 | 34.98 | 14.05 | 11.40 | -13.06 | -33.90 | -67.37 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| ROE %i | 7.54 | 7.86 | 7.22 | 6.70 | 7.21 | 7.33 |
| ROA %i | 5.21 | 5.36 | 4.89 | 4.53 | 4.97 | 4.97 |
| ROIC %i | 6.73 | 6.96 | 6.41 | 5.96 | 6.44 | 6.51 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | 2.65 | 2.62 | 2.44 | 2.29 | 2.55 | 2.49 |
| FCF / sales %i | -- | -- | -- | 0.07 | 0.45 | 0.76 |
| Current ratioi | 2.47 | 2.01 | 1.94 | 1.93 | 2.04 | 2.03 |
| Quick ratioi | 1.38 | 0.92 | 0.88 | 0.99 | 1.00 | 1.01 |
| Debt / assetsi | 8.09 | 8.64 | 8.68 | 8.49 | 8.57 | 8.33 |
| LT debt / equityi | 8.81 | 9.78 | 10.09 | 9.80 | 9.78 | 9.41 |
| Interest coveragei | -- | -- | -- | -- | -- | -- |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
✦ Quant Revenue Concentration how this is computed
Single-engine
- Grocery is the largest reported line at 78.66% of revenue, across 5 reported segments.
- The next-largest line, Pharmacy, is a distant second at 13.11% - a sharp slowdown here would have little to offset it.
Revenue breakdown most recent period
Business
Grocery78.66%
Pharmacy13.11%
Fuel7.70%
Other revenue0.35%
Manufacturing0.18%
Quote time 2026-10-08 07:24:29 · For reference only, not investment advice and not tailored to your situation.